| Tag | Content |
|---|
EnhancerAtlas ID | HS093-20106 |
Organism | Homo sapiens |
Tissue/cell | HL-60 |
Coordinate | chr21:34740270-34740870 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Nr2f6(var.2) | MA0728.1 | chr21:34740462-34740477 | TGAACTCCTGACCTC | - | 6.22 | | SPI1 | MA0080.4 | chr21:34740592-34740606 | AGAAAGAGGAAGTT | + | 6.7 | | SPIC | MA0687.1 | chr21:34740592-34740606 | AGAAAGAGGAAGTT | + | 6.24 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_10924 | chr21:34738868-34748742 | CD20 | | SE_58466 | chr21:34731200-34786233 | Ly1 | | SE_60169 | chr21:34732700-34761220 | Ly4 | | SE_60632 | chr21:34732666-34757447 | DHL6 | | SE_61512 | chr21:34731229-34778660 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH21I033368 | chr21 | 34740521 | 34740670 |
|
Enhancer Sequence | GTTTCGCTCT GTCGCCCAGG CTGGAGTGCA GTGGCACAAT CTCAGCTCAC TGCAATCTCT 60
GCCTCCTGGA TTCAAGCGAT TCTCCTGCCT CAGCCTCCCA AGTAGCTGGG ATTACAGGCA 120
CCCACCACCA TGCCCAGCTA ATTTTTGTAT TTTAGTAGAG ACGGGGTTTC ACCATGTTGG 180
CCAGGCTGGT CTTGAACTCC TGACCTCAGG TGATTCTCCC ACTTCAGCCT CCCAAAGCGT 240
TTGGATTACA GGCATGAGCC ACCACACCCA GCCAAGCTTA TCTGTTTTCA ATTGTGTGTG 300
TGTGTGTGTG TGCACATGAG AGAGAAAGAG GAAGTTACAT TTATGAGACT GATAGTGGCA 360
AGAGGCAGGC AAATGCCTAG GCAGATAACA GCGGGTCCCT GGTGAAACCC CACTGCCAAG 420
CCAAAAACAG TTTAAAGCCT GAAAGTCAAG CTACAGGTCA CATCCACGGA CTGGATTGAG 480
AACCTGTCTT CCCATTTGGT GCACTTTCCT CTGATTGAGC CCCACCCTTC ACCTGTTTTA 540
TATATACCTC CTAATTGGTT CTCTACACTG TCATGCCCAC CTTTCAGTGG TGTCTTTGCT 600
|
